HSBC Holdings
AVXL icon

HSBC Holdings’s Anavex Life Sciences AVXL Stock Holding History

HSBC Holdings’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
102,925
-4,931
-5% -$14.6K ﹤0.01% 2567
2026
Q1 		$330K Buy
107,856
+79,072
+275% +$342K ﹤0.01% 2413
2025
Q4 		$104K Buy
+28,784
New +$176K ﹤0.01% 2786
2025
Q1 		– Sell
-10,347
Closed -$110K – 3040
2024
Q4 		$110K Buy
10,347
+302
+3% +$2.32K ﹤0.01% 2873
2024
Q3 		$56.5K Buy
+10,045
New +$58K ﹤0.01% 2872
2024
Q2 		– Sell
-10,407
Closed -$52.9K – 2941
2024
Q1 		$52.9K Buy
+10,407
New +$58.6K ﹤0.01% 2933

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HSBC Holdings's AVXL Position: Q2 2026 in Review

HSBC Holdings reduced its Anavex Life Sciences (AVXL) stake by 4.6% in Q2 2026, selling an estimated $14.6K and leaving 102,925 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

HSBC Holdings first reported a position in AVXL in Q1 2024 and has held it in 6 quarters since. The position peaked at $330K in Q1 2026. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • HSBC Holdings held 102,925 shares of Anavex Life Sciences worth $270K as of Q2 2026.
  • HSBC Holdings sold 4,931 Anavex Life Sciences shares in Q2 2026, an estimated $14.6K.
  • Anavex Life Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2567 holding.
  • HSBC Holdings first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 6 quarters since.
  • HSBC Holdings's Anavex Life Sciences position peaked at $330K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.